List of medicinal products under additional monitoring

List of medicinal products under additional monitoring

The role of members representing patients' and healthcare professionals' organisations on EMA scientific committees

Human medicines European public assessment report (EPAR): Vaniqa, eflornithine, Date of authorisation: 19/03/2001, Revision: 24, Status: Authorised

Minutes of the PRAC meeting on 30 September - 03 October 2024

Human medicines European public assessment report (EPAR): Cervarix, human papillomavirus vaccine [types 16, 18] (recombinant, adjuvanted, adsorbed), Date of authorisation: 20/09/2007, Revision: 42, Status: Authorised

List of medicines currently in PRIME scheme

LinkedIn Live session: Improving efficiency of approval process for new medicines in the EU , Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 5 December 2024, 12:30 (CET) to 5 December 2024, 13:30 (CET)

Thirteenth meeting of the industry stakeholder platform on the operation of the centralised procedure for human medicines, Online, European Medicines Agency, Amsterdam, the Netherlands, from 22 November 2024, 09:00 (CET) to 22 November 2024, 14:00 (CET)

Opinion/decision on a Paediatric investigation plan (PIP): Nuvaxovid, Severe acute respiratory syndrome coronavirus 2 recombinant spike protein nanoparticle vaccine/ matrix-M1 adjuvant (NVX-CoV2373), decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Vaccines, PIP number: P/0423/2023